Project Description
Updates from the CBTP Lab
The lab team at the Children’s Brain Tumor Project is working at an unprecedented pace in order to advance cures. Our team is focused on two strategic paths forward: (1) basic research toward breakthrough discoveries, and (2) translational research that will enable us to bring those discoveries to clinic.
Global Observership in Intraventricular Neuro-Endoscopy (Non-Clinical)
August 18, 2026 - Dr. Mark Souweidane announces the launch of a new opportunity for neurosurgeons to apply for an observership in endoscopic approaches under his mentorship at Weill Cornell Medicine.
The Luciani Family is Doing Something
June 1, 2026 - Dr. Mark Souweidane co-authored a national consensus study establishing standardized outcome measures for pediatric brain tumor surgery, helping improve research quality and patient care across institutions.
Improving How Success Is Measured After Pediatric Brain Tumor Surgery
June 1, 2026 - Dr. Mark Souweidane co-authored a national consensus study establishing standardized outcome measures for pediatric brain tumor surgery, helping improve research quality and patient care across institutions.
CBTP Welcomes Summer Interns 2026
February 1, 2026 - Weill Cornell Medicine investigators have received a $100,000 grant from the GC Global consortium to study diffuse pediatric brain tumors, including gliomatosis cerebri. The project will develop standardized tools combining imaging and molecular data to better understand how these tumors spread through the brain.
No Laughing Matter 2026 Honors Gretchen Scott
May 28, 2026 - The 2026 Comedy Gala will be held on October 22 at the New York Athletic Club, bringing together 300 distinguished guests in support of pediatric brain tumor research. This year’s gala will honor designer Gretchen Scott for her early and lasting connection to Elizabeth’s Hope and her support of our mission at the CBTP.
Dr. Souweidane Presents on Innovations in Surgical Oncology
May 20, 2026 - Dr. Souweidane was recently invited to present on advances in surgical neurooncology and the field’s shift toward more precise and innovative approaches at 3 national conferences/meetings.